Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Convulsive Generalized Seizure Disorder

3,4-methylenedioxyamphetamine has been researched along with Convulsive Generalized Seizure Disorder in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Research Excerpts

ExcerptRelevanceReference
"This drug abuse is rarely reported spontaneously."1.29[Epileptic insults, cerebral infarction and rhabdomyolysis as complications of amphetamine use]. ( Korten, JJ; Roebroek, RM, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roebroek, RM1
Korten, JJ1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Convulsive Generalized Seizure Disorder

ArticleYear
[Epileptic insults, cerebral infarction and rhabdomyolysis as complications of amphetamine use].
    Nederlands tijdschrift voor geneeskunde, 1996, Jan-27, Volume: 140, Issue:4

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Cerebral Infarction; Designer Drugs; Epilepsy, Generalize

1996